Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

TMC receives option to acquire surgical sealants maker ProFibrix for $10mm up front; option exercised

Executive Summary

The Medicines Co. (TMC; critical care products) has paid $10mm up front for an option to acquire privately held ProFibrix BV (topical surgical sealants used in hemostasis and tissue healing), which would become a wholly owned subsidiary.
Deal Industry
  • Biotechnology
  • Medical Devices
    • Surgical Equipment & Devices
      • Surgical Sealants
Deal Status
  • Final
Deal Type
  • Acquisition
    • Intra-Biotech Deal
    • Includes Earnout
    • Payment Includes Cash
    • Acquisition of Private Biotech
    • Full Acquisition

Related Companies